Bladder cancer is characterised by the abnormal growth of cells lining the bladder and is one of the few cancers where early medical treatment can significantly improve long-term outcomes. In selected patients, particularly those with more invasive disease, treatment with chemotherapy — and in some cases targeted therapy — before surgery can reduce the risk of recurrence and improve survival.

Bladder cancer has some of the strongest clinical evidence supporting this approach, making early specialist assessment especially important. Identifying who is most likely to benefit from systemic treatment before surgery is a key part of modern bladder cancer care.

For consultation, Dr Dilanka De Silva can help guide you through multidisciplinary bladder cancer care and ensure treatment decisions are made at the right time, using the most effective evidence-based strategies.